Analysis
Filter results by
Search HelpKeyword(s)
Subject
Survey or statistical program
Results
All (2)
All (2) ((2 results))
- Articles and reports: 88F0006X2003013Description:
This paper used data from the 2001 Biotechnology Use and Development Survey (BUDS) to look into bioproduct development using biotechnologies. Results show that the development of bioproducts has become an intrinsic part of the activities of Canadian biotechnology firms.
Release date: 2003-12-08 - Articles and reports: 88-003-X20030026570Geography: CanadaDescription:
In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?
Release date: 2003-06-27
Articles and reports (2)
Articles and reports (2) ((2 results))
- Articles and reports: 88F0006X2003013Description:
This paper used data from the 2001 Biotechnology Use and Development Survey (BUDS) to look into bioproduct development using biotechnologies. Results show that the development of bioproducts has become an intrinsic part of the activities of Canadian biotechnology firms.
Release date: 2003-12-08 - Articles and reports: 88-003-X20030026570Geography: CanadaDescription:
In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?
Release date: 2003-06-27